Profile
RNXT VRTX REGN SGEN ARGX ALNY
Company Name RenovoRx, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $35.56M $123.21B $76.06B $43.15B $37.83B $31.65B
Employees 0.01K 6.10K 15.11K 3.26K 1.15K 2.23K
CEO Mr. Shaun R. Bagai Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
Trading
RNXT VRTX REGN SGEN ARGX ALNY
Last Close $0.91 $500.01 $744.83 $228.74 $571 $233.07
High 52 $1.69 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.9 $392.81 $663.86 $228.74 $356.01 $143.31
Price vs. 52 Week High -46.15 % -3.24 % -38.02 % 0 % -15 % -21.46 %
Price vs. 52 Week Low 1.11 % 27.29 % 12.2 % 0 % 60.39 % 62.63 %
Total Return
RNXT VRTX REGN SGEN ARGX ALNY
1 Month Return -20.87 % 9.83 % 11.93 % 0 % -10.22 % -13.35 %
3 Month Return -35.46 % 6.77 % -3.64 % 0 % -5.76 % -8.29 %
6 Month Return -13.38 % 5.32 % -34.75 % 0 % 6.25 % -11.01 %
9 Month Return -13.33 % 3.84 % -26.29 % 0 % 51.54 % 48.99 %
YTD Return -29.46 % 24.16 % 4.56 % 0 % -7.15 % -0.95 %
1 Year Return -46.15 % 20.64 % -22.77 % 0 % 48.31 % 56.32 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RNXT VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.12 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 5.37 % -2.27 % -2.22 % -0.24 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
RNXT VRTX REGN SGEN ARGX ALNY
Asset Growth -79.82 % -0.87 % 44.93 % 10.71 %
Gross Profit Growth 100 % 10.25 % 190.7 % 26.81 %
Revenue Growth - 11.66 % 198.56 % 22.97 %
Revenue 3 Year - 45.6 % 2071.96 % 145.29 %
Revenue 5 Year - 163.93 % 3041.46 % 769.33 %
Revenue 10 Year - 1632.15 % 9009.53 % 2468.51 %
EBIT Growth -14.53 % -105.41 % 40.94 % 37.31 %
Net Income Growth -4.72 % -114.8 % 58.42 % 36.82 %
Net Income 3 Yeari Growth Per Share -96.41 % -122.89 % 64.01 % 69.96 %
Net Income 5 Yeari Growth Per Share -128.08 % -145.38 % -143.65 % 73.33 %
Net Income 10 Yeari Growth Per Share -128.08 % 33.84 % -857 % 55.42 %
Operating Income Growth -14.53 % -105.41 % 40.94 % 37.31 %
Operating Cash Flow Growth (CFG) -16.42 % -113.93 % 51.28 % -107.98 %
Operating 3 Year CFG -144.74 % -118.65 % 21.71 % 98.81 %
Operating 5 Year CFG -157.74 % -131.3 % -329.63 % 97.46 %
Operating 10 Year CFG -157.74 % 12.43 % -1280.2 % 97.1 %
EPS Growth 8.33 % -114.8 % 60.46 % 38.64 %
EPS Diluted Growth 8.33 % -114.97 % 60.46 % 38.64 %
Book Value Per Share -142.82 % -6.59 % 38.53 % 129.53 %
Share Holder 3 Year Equity Growth Per Share 82.77 % 62.6 % 94.42 % -89.49 %
Share Holder 5 Year Equity Growth Per Share 76.89 % 168.85 % 318.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share 76.89 % 1265.7 % 3654.06 % -95.86 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 116.42 % 60.95 % -51.69 %
Free Cash Flow Growth -16.42 % -124.1 % 51.98 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2023 31 Dec 2024
Profitability
RNXT VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM - 86.09 % 84.47 % 72.37 % 86.82 % 85.62 %
Return on Assets TTM -91.35 % -2.38 % 11.69 % -11.76 % -2.13 % -6.56 %
Return on Equity TTM -242.57 % -3.28 % 14.77 % -16.53 % -2.75 % 905.33 %
Return on Capital Employed TTM -122.47 % -1.3 % 10.89 % -16.87 % -8.98 % -5.79 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 167.72 % 73.71 %
EBT Per Ebit TTM 90.59 % -100.69 % 118.85 % 94.01 % 15.76 % 213.34 %
EBIT Per Revenue TTM - -2.24 % 28.32 % -36.09 % -17.08 % -7.87 %
Cash Flow To Debt Ratio TTM - -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Receivables Turnover TTM - 6.84 2.29 1.98 3.45 5.55
Payables Turnover TTM - 3.71 2.79 1.54 1.06 3.66
Inventory Turnover TTM - 1.27 0.71 0.65 0.91 4.12
Fixed Asset Turnover TTM - 425.82 % 308.76 % 256.83 % 6116.64 % 323.99 %
Asset Turnover TTM - 48.84 % 37.61 % 34.46 % 47.09 % 53.02 %
Operating Cash Flow Per Share TTM -0.35 -1.91 41.08 -1.12 -2.42 -0.06
Free Cash Flow Per Share TTM -0.35 -3.07 33.43 -1.62 -3.52 -0.33
Cash Per Share TTM 38.34 % 2375.11 % 16647.4 % 657.5 % 5163.05 % 2095.42 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 31.13 % -16.85 % -6.44 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 81.38 % 144.14 % 145.12 % 512.38 %
Cash Flow Coverage Ratios TTM - -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Price To Free Cash Flows Ratio TTM -4.07 -155.9 21.15 -141.85 -179.11 -743.26
Price To Operating Cash Flows Ratio TTM -2.85 -250.8 17.22 -203.89 -257.05 -3782.82
Price Cash Flow Ratio TTM -2.85 -250.8 17.22 -203.89 -257.05 -3782.82
Income Statement (TTM)
RNXT VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $1.23B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.11B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 90.39% 85.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.22B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.3B $-0.28B
EPS Diluted -0.99 -2.08 38.34 -3.3 -5.16 -2.16
Balance Sheet (MRQ)
RNXT VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.04B $0.02B $0B
Total Liabilities $0B $6.12B $8.41B $0.87B $0.44B $4.17B
Total Equity $-0B $16.41B $29.35B $2.8B $4.1B $0.07B
Total Investments $0B $6.65B $6.52B $1.42B $1.18B $1.73B
Total Debt $0B $1.75B $2.7B $0.04B $0.02B $1.3B
Total Assets $0B $22.53B $37.76B $3.67B $4.54B $4.24B
Cash Flow Statement (TTM)
RNXT VRTX REGN SGEN ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.43B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.08B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.42B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.04B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.9
AAPG 18.845
ABCL AbCellera Biologics Inc. 2.235
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.45
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.28
ABPWW 0.0302
ABSI Absci Corporation 2.955
ABUS Arbutus Biopharma Corporation 3.05
ABVC ABVC BioPharma, Inc. 0.655
ABVX Abivax SA American Depositary Shares 6.39
ACAD ACADIA Pharmaceuticals Inc. 17.18
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7755
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.39
ACHV Achieve Life Sciences, Inc. 2.91
ACIU AC Immune SA 2.24
ACLX Arcellx, Inc. 68.44
ETFs With Exposure to RNXT
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 273.75
VXF Vanguard Extended Market Index Fund 0 172.82
IWC iShares Micro-Cap ETF 0.00269 114.02
VTSAX Vanguard Total Stock Market Index Fund 0 134.15
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 130.87
VITSX Vanguard Total Stock Market Index Fund 0 134.17
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000244559 94.21
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 130.88
VEMPX Vanguard Extended Market Index InstlPlus 0 322.98
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 251.68
Unlock